ReviewFrontiers in endocrinology2018

Targeting Fibroblast Growth Factor 23 Signaling with Antibodies and Inhibitors, Is There a Rationale?

Seiji FukumotoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.